We are live on ! Find out more
DMAQR

Deep Medicine Acquisition Corp. Rights
DMAQR

Delisted

DMAQR was delisted on the 31st of January, 2024.

Back to rankings

24 hedge funds and large institutions have $1.85M invested in Deep Medicine Acquisition Corp. Rights in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 8 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% less funds holding

Funds holding: 26 → 24 (-2)

23% less capital invested

Capital invested by funds: $2.4M → $1.85M (-$547K)

75% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 8

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
24
Holders Change
-2
Holders Change %
-7.69%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
8
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SOA
Sea Otter Advisors
Florida
+$46.3K
2
CS
Clear Street
New York
+$1.5K

Top Sellers

Rank Fund Capital Flow
1
HCM
Highbridge Capital Management
New York
-$73.4K
2
SCM
Shaolin Capital Management
Florida
-$46.3K
3
YCM
Yakira Capital Management
Connecticut
-$46.3K
4
KPF
K2 Principal Fund
Ontario, Canada
-$45.1K
5
Parallax Volatility Advisers
Parallax Volatility Advisers
California
-$43.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
HCM
1
Highbridge Capital Management
New York
$229K -$73.4K -237,699 -24%
OCAM
2
Owl Creek Asset Management
New York
$217K -$8.45K -27,361 -4%
CAC
3
Cowen and Company
New York
$166K -$36.5K -118,047 -18%
YCM
4
Yakira Capital Management
Connecticut
$147K -$46.3K -149,869 -23%
AA
5
AQR Arbitrage
Connecticut
$111K – – –
SCM
6
Shaolin Capital Management
Florida
$90K -$46.3K -150,000 -33%
SOA
7
Sea Otter Advisors
Florida
$90K +$46.3K +150,000 +100%
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
$89K – – –
Walleye Capital
9
Walleye Capital
New York
$80.9K -$13.9K -45,000 -14%
WA
10
Whitebox Advisors
Minnesota
$75K – – –
PC
11
Periscope Capital
Ontario, Canada
$72.6K – – –
CH
12
CVI Holdings
Delaware
$69.2K – – –
MTCM
13
Mint Tower Capital Management
Netherlands
$58K – – –
SCM
14
Saba Capital Management
New York
$50.7K – – –
PL
15
Parkwood LLC
Ohio
$47K – – –
Walleye Trading
16
Walleye Trading
New York
$45.5K – – –
RCM
17
Rivernorth Capital Management
Florida
$45K – – –
KPF
18
K2 Principal Fund
Ontario, Canada
$40.4K -$45.1K -145,847 -52%
CS
19
Clear Street
New York
$31.3K +$1.5K +4,845 +5%
FLC
20
Fifth Lane Capital
Texas
$30K – – –
MC
21
Meteora Capital
Florida
$24.2K – – –
TCM
22
Tuttle Capital Management
Connecticut
$20.7K – – –
HF
23
HRT Financial
New York
$14K -$375 -1,215 -2%
Millennium Management
24
Millennium Management
New York
$9.9K – – –
Parallax Volatility Advisers
25
Parallax Volatility Advisers
California
– -$43.4K -124,352 Closed
1
2

DMAQR Hedge Fund Activity: Q4 2023 in Review

24 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Deep Medicine Acquisition Corp. Rights (DMAQR) for Q4 2023, worth a combined $1.85M — down 23% from $2.4M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of DMAQR and 0 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 2 added.

The largest buyer was Sea Otter Advisors, adding an estimated $46.3K. The largest seller was Highbridge Capital Management, cutting an estimated $73.4K.

  • 24 institutional investors held Deep Medicine Acquisition Corp. Rights (DMAQR) as of Q4 2023, down from 26 in Q3 2023.
  • Funds reported $1.85M of Deep Medicine Acquisition Corp. Rights stock for Q4 2023, down 23% quarter-over-quarter.
  • 0 funds opened new Deep Medicine Acquisition Corp. Rights positions in Q4 2023 and 2 closed out, a net change of -2 holders.
  • The largest Deep Medicine Acquisition Corp. Rights buyer in Q4 2023 was Sea Otter Advisors, an estimated $46.3K added.
  • The largest Deep Medicine Acquisition Corp. Rights seller in Q4 2023 was Highbridge Capital Management, an estimated $73.4K sold.

Based on aggregated 13F filings for Q4 2023.